These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16297492)

  • 1. Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients.
    Varela M; Bruix J
    J Hepatol; 2006 Jan; 44(1):8-10. PubMed ID: 16297492
    [No Abstract]   [Full Text] [Related]  

  • 2. Underutilization of therapy for hepatocellular carcinoma in the medicare population.
    Shah SA; Smith JK; Li Y; Ng SC; Carroll JE; Tseng JF
    Cancer; 2011 Mar; 117(5):1019-26. PubMed ID: 20945363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in renal transplantation recipients.
    Lai MK; Huang CC; Chu SH; Jeng LB; Chuang CK; Chen HW; Chen CS
    Transplant Proc; 1994 Aug; 26(4):1979-80. PubMed ID: 8066640
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for hepatocellular carcinoma in clinical practice: miles to go before we sleep.
    Kallwitz ER; Cotler SJ
    J Clin Gastroenterol; 2007 Sep; 41(8):729-30. PubMed ID: 17700420
    [No Abstract]   [Full Text] [Related]  

  • 5. The rising incidence of hepatocellular carcinoma.
    Kaczynski J; Odén A
    N Engl J Med; 1999 Aug; 341(6):451; author reply 452. PubMed ID: 10438267
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Dr. Ruffin.
    Borges AM; Swaroop VS; Desai PB
    Am J Gastroenterol; 1991 Jun; 86(6):789-90. PubMed ID: 1645499
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India.
    Aggarwal R
    Trop Gastroenterol; 2008; 29(4):183-6. PubMed ID: 19323085
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Shah S; Thompson D
    J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma.
    Desmet VJ
    Hepatology; 2009 Feb; 49(2):355-7. PubMed ID: 19127518
    [No Abstract]   [Full Text] [Related]  

  • 11. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
    Martin RC; Loehle J; Scoggins CR; McMasters KM
    Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2005 Sep; 129(3):1132-4. PubMed ID: 16143155
    [No Abstract]   [Full Text] [Related]  

  • 13. The risk of hepatocellular carcinoma in patients with previous malignancy.
    Siegel AB; McBride RB; El-Serag HB; Hershman D; Brown RS; Zablotska L; Neugut AI
    Cancer Invest; 2008 Jun; 26(5):511-5. PubMed ID: 18568774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Why so high incidence of HCC in Japan?].
    Mizokami M
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1055-7. PubMed ID: 19620790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and biological trends in liver cancers at a University hospital in Southwest Nigeria.
    Otegbayo JA; Oluwasola OA; Akere A; Ogunbiyi JO
    Trop Doct; 2006 Jan; 36(1):28-30. PubMed ID: 16483427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma].
    Gilsanz García V
    An R Acad Nac Med (Madr); 1988; 105(3):387-409. PubMed ID: 2851944
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological surveillance for hepatocellular carcinoma: time to quit.
    Sherman M
    J Hepatol; 2010 Apr; 52(4):614-5. PubMed ID: 20185193
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma.
    Naugler WE; Schwartz JM
    Dis Mon; 2008 Jul; 54(7):432-44. PubMed ID: 18570913
    [No Abstract]   [Full Text] [Related]  

  • 19. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.